Back to Journals » Drug Design, Development and Therapy » Volume 18

Review

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

       
Total article views   HTML views PDF downloads Totals
2,039 Dovepress* 1,880+ 51 1,931
PubMed Central* 159 69 228
Totals 2,039 120 2,159
*Since 8 February 2024

View citations on PubMed Central and Google Scholar